The name of the company has been changed from Laurel Organics Limited to Kimia Biosciences Limited with effect from 04-01-2019 pursuant to the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited-Transferor Company-with Laurel Organics Limited -Transferee Company-as per the approval and Order of Honrable NCLT Chandigarh.
+91-11-4706 3600
info@kimiabiosciences.com

Management Team

Mr. Sameer Goel

MD

Mr. Sameer Goel is the Managing Director and heading Kimia Biosciences.™ He holds a tall stature in the Indian API market and has strong multi-dimensional capabilities in the areas of Business Development, Product Development, Strategic Marketing and Operations Management. He has played a key leadership role with various organizations in acquiring and aligning the strong support of professional networks, business partners and executive teams to accomplish expertise in manufacturing, sales, marketing and trading of various APIs and its Intermediates.

Currently , Mr. Goel is responsible for providing overall leadership in achieving business & product development goals and formation of strategic partnerships in Business

Mr. Sanjay Gupta

CFO

Mr. Sanjay Gupta is looking after finance and accounts operations of the company. He has an experience of 22 years in Finance. Prior joining Kimia he was associated with Kusum Bhaskar Group, H-one India PVT limited, Focus Biotech, Mudra Life style Limited, Paramount Communications Limited, Ruchi Soya Industries. He has an exposure on overall Accounts and finance , funds management, direct and indirect taxation, Plant commercial and operations, Strategic planning and costing, banking operation, MIS & Internal Controlling.

He is a Chartered Accountant from ICAI, New Delhi and possesses the degree of B.Com. from University of Kurukshetra.

Dr. Mukesh Kr. Sharma

Head-R&D

Mr. Mukesh Kr. Sharma is heading the R&D. He brings a very varied and rich experience of over 21+years in the pharmaceutical Industry. He is highly competent & experienced in Technology development portfolios. Prior to joining Kimia Biosciences Ltd., he has worked with reputed organizations including Pharmaceutical Co. of India Ranbaxy and Sun Pharmaceuticals Industries Ltd. He has domain expertise in critical areas of Research & Development / scale up of API with knowledge of product identification, budgeting exercise, strategies and planning for development and project execution, review and management of project progress and overall assessment, requirements of guidelines/SOPs & simplification for smooth functioning of the function.

He holds a degree in Ph.D. (Synthesis of Heterocyclic Bioactive compounds), Delhi University. Dr. Mukesh is an effective communicator with strong people management, coordination, planning, analytical and problem-solving abilities.

A. S. Bisla

Advisor- Indirect Taxation

A. S. Bisla is looking after the indirect taxation of the company. He is LL B from Delhi University and has 34+ years of practical experience in divergent responsibilities and in-depth knowledge in Legal compliances, due diligence, audit of accounts, agreements, Central Excise, Customs, Service Tax, Imports and Export procedures and applications of Allied Laws including Drugs, Food, wild life, telecommunications, DGFT etc and Licenses in imports and manufacturing activities.

He has served for 32+ years in the executive and supervisory responsibilities with the Government of India in Customs and Central Excise Department with exposure to the Tax compliance, Imports/ exports, Drawback and other export incentives, Adjudications/ Appeals, Allied Acts compliances, 

Dr. Rita Sarin

Advisor - Strategy & IPR

Dr. Rita Sarin is an Advisor and heading IPR and Strategic Management at Kimia Biosciences Ltd. She is Ph.D. degree in Medicinal Chemistry from Central Drug Research Institute (CDRI), Lucknow and has 24 years of extensive experience in various aspects of Intellectual Property. She has previously worked at Ranbaxy (now Sun Pharma) and Lupin Research Laboratories. She has received an award from the President of India, late Shri Dr. Abdul Kalam Azad in 2012 for the launch of Synriam TM, the first drug developed in India.

Dr. Yatender Kumar

Advisor - Strategy & R&D

orem ipsum dolor sit amet, consectetur adipisicing elit. Cumque beatae repellendus nesciunt similique, ut deleniti molestiae blanditiis commodi, ipsum reprehenderit non dolorum eius totam, necessitatibus quod. Dignissimos ullam porro, cum?